Neovii and Fosun Pharma Enter Into an Exclusive Agreement

Neovii and Fosun Pharma Enter into an Exclusive Agreement for Development and Commercialization for Grafalon in China...

Related Keywords

China ,Taiwan ,Rapperswil ,Switzerland General ,Switzerland ,Hong Kong ,United Kingdom ,Macau ,Chinese ,Swiss ,Wen Deyong ,Neovii Grafalon ,Marshal Ma ,Fosun Pharma ,Ltd Fosun Pharma Industry ,Sinopharm Co Ltd ,Shanghai Fosun Pharmaceutical Group Co Ltd ,Shanghai Fosun Pharmaceutical Industry Development Co ,Link China Pharma Solutions Cambridge ,Neovii Pharmaceuticals Ag ,China National Reimbursement Drug List ,Neovii Pharmaceuticals ,Neopharm Group ,Shanghai Fosun Pharmaceutical ,Stock Code ,Fosun Pharma Industry ,Chinese Mainland ,Agreement Neovii ,National Reimbursement Drug ,Host Disease ,Christian Loss ,Link China Pharma Solutions ,Consumer Healthcare ,Fosun Logo ,Ommercialization ,Development ,Harmaceutical ,